Monsanto Co. (NYSE:MON) received a $128.00 price objective from equities research analysts at JPMorgan Chase & Co. in a research report issued on Thursday. The firm currently has a a “buy” rating on the stock. JPMorgan Chase & Co.’s price target would indicate a potential upside of 23.67% from the stock’s previous close.

Several other equities analysts have also recently issued reports on MON. Zacks Investment Research upgraded Monsanto from a “sell” rating to a “hold” rating in a research report on Wednesday, June 8th. Piper Jaffray Cos. restated an “overweight” rating and issued a $127.00 price target (up previously from $95.00) on shares of Monsanto in a research report on Monday, June 13th. Argus reiterated a “buy” rating and set a $128.00 target price (up previously from $111.00) on shares of Monsanto in a research report on Wednesday, June 15th. Goldman Sachs Group Inc. set a $92.00 target price on Monsanto and gave the stock a “sell” rating in a research report on Monday, June 27th. Finally, Vetr upgraded Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 target price on the stock in a research report on Monday, June 27th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $114.67.

Analyst Recommendations for Monsanto (NYSE:MON)

Shares of Monsanto (NYSE:MON) traded up 0.09% during trading on Thursday, reaching $103.59. The company’s stock had a trading volume of 1,577,526 shares. The firm has a market capitalization of $45.33 billion, a P/E ratio of 45.59 and a beta of 1.19. Monsanto has a 52 week low of $83.73 and a 52 week high of $114.26. The company has a 50 day moving average price of $104.88 and a 200 day moving average price of $101.34.

Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. The firm had revenue of $2.56 billion for the quarter, compared to analysts’ expectations of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.19) EPS. On average, equities research analysts expect that Monsanto will post $4.89 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.09%. Monsanto’s dividend payout ratio is presently 71.05%.

In other news, CEO Michael K. Stern sold 12,797 shares of the firm’s stock in a transaction dated Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the sale, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Brett D. Begemann sold 27,980 shares of the firm’s stock in a transaction dated Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the sale, the chief operating officer now owns 102,480 shares of the company’s stock, valued at $10,618,977.60. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.

Several hedge funds have recently made changes to their positions in MON. Mycio Wealth Partners LLC increased its stake in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares in the last quarter. Moody National Bank Trust Division increased its stake in shares of Monsanto by 0.3% in the second quarter. Moody National Bank Trust Division now owns 4,883 shares of the company’s stock valued at $505,000 after buying an additional 15 shares in the last quarter. Quadrant Capital Group LLC increased its stake in shares of Monsanto by 0.9% in the second quarter. Quadrant Capital Group LLC now owns 1,858 shares of the company’s stock valued at $184,000 after buying an additional 16 shares in the last quarter. Advisor Partners LLC increased its stake in shares of Monsanto by 0.4% in the second quarter. Advisor Partners LLC now owns 6,238 shares of the company’s stock valued at $645,000 after buying an additional 23 shares in the last quarter. Finally, Trust Co. of Vermont increased its stake in shares of Monsanto by 0.6% in the second quarter. Trust Co. of Vermont now owns 4,932 shares of the company’s stock valued at $510,000 after buying an additional 30 shares in the last quarter. Institutional investors own 79.02% of the company’s stock.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.